Skip to main content

Advertisement

Log in

Hemostatic matrix effects on blood loss after total knee arthroplasty: A randomized controlled trial

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Background: Total knee arthroplasty (TKA) can result in major postoperative blood loss which can impact on the recovery and rehabilitation of patients. It also requires expensive transfusions. The purpose of the study was to investigate whether a hemostatic matrix, composed of cross-linked gelatin and a thrombin solution, would reduce blood loss in patients following TKA.

Materials and Methods: This was a prospective, randomized, controlled study (Trial registration: Hospital S. Salvatore LAquila ADJ00843) conducted in 93 patients. Criteria for participation were unilateral TKA for osteoarthritis, and a preoperative hemoglobin level >13 g/dL. The outcomes measured were postoperative hemoglobin and hematocrit levels measured at 24h, 72 h, and 7 days. The mean total postoperative blood loss was calculated from drainage volume, patient blood volume, hematocrit, and red blood cell volume. In addition, the drain output within 24 h following surgery and any transfusion requirements were determined.

Results: Hemostatic matrix-treated patients (n = 51) showed signifcant reductions in calculated postoperative blood loss of 32.3% and 28.7% versus control in men and women, respectively (P < 0.01). Postoperative blood loss after 24 h in drain was signifcantly less with the hemostatic matrix versus control, as were decreases in hemoglobin levels 7 days post-surgery (each P < 0.01). Three patients in the control group required blood transfusion, whereas no blood transfusions were necessary in the hemostatic matrix group.

Conclusion: The use of a hemostatic matrix provides a safe and effective means to reduce blood loss and blood transfusion requirements in TKA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008;90;1128–36.

    Article  CAS  PubMed  Google Scholar 

  2. Lotke PA, Faralli VJ, Orenstein EM, Ecker ML. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Joint Surg Am 1991;73;1037–40.

    Article  CAS  PubMed  Google Scholar 

  3. Walker RH. Special report: Transfusion risks. Am J Clin Pathol 1987;88;374–8.

    Article  CAS  PubMed  Google Scholar 

  4. Fiebig E. Safety of the blood supply. Clin Orthop Relat Res 1998;357;6–18.

    Article  Google Scholar 

  5. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: Benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004;70;15–28.

    Article  PubMed  Google Scholar 

  6. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am 1996;78;1260–70.

    Article  CAS  PubMed  Google Scholar 

  7. Rizzi L, Bertacchi P, Ghezzi LM, Bellavita P, Scudeller G. Postoperative blood salvage in hip and knee arthroplasty. A prospective study on cost effectiveness in 161 patients. Acta Orthop Scand 1998;69;31–4.

    PubMed  CAS  Google Scholar 

  8. Nakahara M, Sakahashi H. Effect of application of a tourniquet on bleeding factors in dogs. J Bone Joint Surg Am 1967;49;1345–51.

    Article  CAS  PubMed  Google Scholar 

  9. Klenerman L, Chakrabarti R, Mackie I, Brozovic M, Stirling Y. Changes in haemostatic system after application of a tourniquet. Lancet 1977;1;970–2.

    Article  CAS  PubMed  Google Scholar 

  10. Petaja J, Myllynen P, Myllyla G, Vahtera E. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 1987;153;647–51.

    PubMed  CAS  Google Scholar 

  11. Radosevich M, Goubran HI, Burnouf T. Fibrin sealant: Scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997;72;133–43.

    Article  CAS  PubMed  Google Scholar 

  12. Oz MC, Cosgrove DM 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000;69;1376–82.

    Article  CAS  Google Scholar 

  13. Reuthebuch O, Lachat ML, Vogt P, Schurr U, Turina M. FloSeal: A new hemostyptic agent in peripheral vascular surgery. Vasa 2000;29;204–6.

    Article  CAS  PubMed  Google Scholar 

  14. Renkens KL Jr, Payner TD, Leipzig TJ, Feuer H, Morone MA, Koers JM, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 2001;26;1645–50.

    Article  Google Scholar 

  15. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngol Head Neck Surg 2004;131;601–5.

    Article  PubMed  Google Scholar 

  16. Richter F, Schnorr D, Deger S, Trk I, Roigas J, Wille A, et al. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal). Urology 2003;61;73–7.

    Article  PubMed  Google Scholar 

  17. Gall RM, Witterick IJ, Shargill NS, Hawke M. Control of bleeding in endoscopic sinus surgery: Use of a novel gelatin-based hemostatic agent. J Otolaryngol 2002;31;271–4.

    Article  PubMed  Google Scholar 

  18. Floseal Hemostatic Matrix Instructions For Use. Available from: http://www.baxter.com/products/biopharmaceuticals/downloads/FloSeal_PI.pdf. [Last Accessed on 2012 Apr 05].

  19. Marmor L, Avoy DR, McCabe A. Effect of fibrinogen concentrates on blood loss in total knee arthroplasty. Clin Orthop Relat Res 1991;273;136–8.

    Google Scholar 

  20. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51;224–32.

    PubMed  Google Scholar 

  21. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: A brief note on a randomized prospective trial. J Bone Joint Surg Am 2001;83-A: 1503–5.

    Article  Google Scholar 

  22. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348;1055–60.

    Article  CAS  PubMed  Google Scholar 

  23. Kim YH, Cho SH, Kim RS. Drainage versus nondrainage in simultaneous bilateral total knee arthroplasties. Clin Orthop Relat Res 1998;347;188–93.

    Article  Google Scholar 

  24. McKenna R, Bachmann F, Kaushal SP, Galante JO. Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg Am 1976;58;928–32.

    Article  CAS  PubMed  Google Scholar 

  25. Stringer MD, Steadman CA, Hedges AR, Thomas EM, Morley TR, Kakkar VV. Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br 1989;71;492–7.

    Article  CAS  PubMed  Google Scholar 

  26. Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA. Preoperative vs Postoperative Initiation of Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients Undergoing Elective Hip Replacement. Arch Intern Med 1999;159;137–41.

    Article  CAS  PubMed  Google Scholar 

  27. Strebel N, Prins M, Agnelli G, Buller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002;162;1451–6.

    Article  CAS  PubMed  Google Scholar 

  28. Perka C. Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: Safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants. Thromb J 2011;9:17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Jameson M, Gross CW, Kountakis SE. Flo Seal use in endoscopic sinus surgery: Effect on postoperative bleeding and synechiae formation. Am J Otolaryngol 2006;27;86–90.

    Article  PubMed  Google Scholar 

  30. Hiippala S, Strid L, Wennerstrand M, Arvela V, Mantyla S, Ylinen J, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995;74;534–7.

    Article  CAS  PubMed  Google Scholar 

  31. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996;78;434–40.

    Article  CAS  PubMed  Google Scholar 

  32. Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I, Hempelmann G. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 2001;92;775–80.

    Article  CAS  PubMed  Google Scholar 

  33. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: A prospective, randomised controlled trial. J Bone Joint Surg Br 2007;89;306–9.

    Article  CAS  PubMed  Google Scholar 

  34. Ortega-Andreu M, Perez-Chrzanowska H, Figueredo R, Gomez-Barrena E. Blood loss control with two doses of tranexamic Acid in a multimodal protocol for total knee arthroplasty. Open Orthop J 2011;5;44–8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006;105;1034–46.

    Article  PubMed  Google Scholar 

  36. Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: A meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20;1742–52.

    Article  PubMed  Google Scholar 

  37. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW. Reducing blood loss in primary knee arthroplasty: A prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee 2012;19;295–8.

    Article  PubMed  Google Scholar 

  38. Ishii Y, Matsuda Y. Perioperative blood loss in cementless or hybrid total knee arthroplasty without patellar resurfacing: A prospective, randomized study. J Arthroplasty 2005;20;972–6.

    Article  PubMed  Google Scholar 

  39. Izzo F, Di Giacomo R, Falco P, Piccirillo M, Iodice R, Pio Orlando A, et al. Efficacy of a haemostatic matrix for the management of bleeding patients undergoing liver resection: Results from 237 cases. Curr Med Res Opin 2008;24;1011–5.

    Article  PubMed  Google Scholar 

  40. Oz MC, Rondinone JF, Shargill NS. Flo Seal Matrix: New generation topical hemostatic sealant. J Card Surg 2003;18;486–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Di Francesco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Francesco, A., Flamini, S., Fiori, F. et al. Hemostatic matrix effects on blood loss after total knee arthroplasty: A randomized controlled trial. IJOO 47, 474–481 (2013). https://doi.org/10.4103/0019-5413.118203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/0019-5413.118203

Key words

Navigation